1. Home
  2. ASTE vs AVXL Comparison

ASTE vs AVXL Comparison

Compare ASTE & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASTE
  • AVXL
  • Stock Information
  • Founded
  • ASTE 1972
  • AVXL 2004
  • Country
  • ASTE United States
  • AVXL United States
  • Employees
  • ASTE N/A
  • AVXL N/A
  • Industry
  • ASTE Construction/Ag Equipment/Trucks
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ASTE Industrials
  • AVXL Health Care
  • Exchange
  • ASTE Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • ASTE 894.3M
  • AVXL 716.1M
  • IPO Year
  • ASTE N/A
  • AVXL N/A
  • Fundamental
  • Price
  • ASTE $33.29
  • AVXL $8.63
  • Analyst Decision
  • ASTE Hold
  • AVXL Strong Buy
  • Analyst Count
  • ASTE 2
  • AVXL 2
  • Target Price
  • ASTE $38.50
  • AVXL $43.00
  • AVG Volume (30 Days)
  • ASTE 130.6K
  • AVXL 1.5M
  • Earning Date
  • ASTE 11-06-2024
  • AVXL 02-05-2025
  • Dividend Yield
  • ASTE 1.56%
  • AVXL N/A
  • EPS Growth
  • ASTE N/A
  • AVXL N/A
  • EPS
  • ASTE N/A
  • AVXL N/A
  • Revenue
  • ASTE $1,283,300,000.00
  • AVXL N/A
  • Revenue This Year
  • ASTE $0.43
  • AVXL N/A
  • Revenue Next Year
  • ASTE $4.02
  • AVXL N/A
  • P/E Ratio
  • ASTE N/A
  • AVXL N/A
  • Revenue Growth
  • ASTE N/A
  • AVXL N/A
  • 52 Week Low
  • ASTE $28.46
  • AVXL $3.25
  • 52 Week High
  • ASTE $44.74
  • AVXL $10.45
  • Technical
  • Relative Strength Index (RSI)
  • ASTE 30.12
  • AVXL 53.18
  • Support Level
  • ASTE $37.18
  • AVXL $7.93
  • Resistance Level
  • ASTE $36.51
  • AVXL $9.48
  • Average True Range (ATR)
  • ASTE 1.28
  • AVXL 0.66
  • MACD
  • ASTE -0.71
  • AVXL -0.07
  • Stochastic Oscillator
  • ASTE 2.85
  • AVXL 55.03

About ASTE Astec Industries Inc.

Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. It has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.

Share on Social Networks: